November 22, 2016 / 12:32 PM / a year ago

BRIEF-Immunovaccine's DPX-Survivac gets orphan drug designation by European medicines agency

Nov 22 (Reuters) - Immunovaccine Inc :

* The european medicines agency grants orphan drug designation status to Immunovaccine’s DPX-Survivac in ovarian cancer Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below